213 related articles for article (PubMed ID: 29749438)
21. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
Lee S; Wottrich S; Bonavida B
Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
[TBL] [Abstract][Full Text] [Related]
22. Deoxycholic Acid Upregulates the Reprogramming Factors KFL4 and OCT4 Through the IL-6/STAT3 Pathway in Esophageal Adenocarcinoma Cells.
Chen M; Ye A; Wei J; Wang R; Poon K
Technol Cancer Res Treat; 2020; 19():1533033820945302. PubMed ID: 32869704
[TBL] [Abstract][Full Text] [Related]
23. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous targeted inhibition of Sox2-Oct4 transcription factors using decoy oligodeoxynucleotides to repress stemness properties in mouse embryonic stem cells.
Johari B; Zargan J
Cell Biol Int; 2017 Dec; 41(12):1335-1344. PubMed ID: 28833847
[TBL] [Abstract][Full Text] [Related]
25. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
26. GRP78 mediates radiation resistance of a stem cell-like subpopulation within the MCF-7 breast cancer cell line.
Li B; Cheng XL; Yang YP; Li ZQ
Oncol Rep; 2013 Nov; 30(5):2119-26. PubMed ID: 24002052
[TBL] [Abstract][Full Text] [Related]
27. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
28. GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer.
Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
Mol Biol Rep; 2024 May; 51(1):691. PubMed ID: 38796671
[TBL] [Abstract][Full Text] [Related]
29. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.
Chung SS; Vadgama JV
Anticancer Res; 2015 Jan; 35(1):39-46. PubMed ID: 25550533
[TBL] [Abstract][Full Text] [Related]
30. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.
Hu T; Liu S; Breiter DR; Wang F; Tang Y; Sun S
Cancer Res; 2008 Aug; 68(16):6533-40. PubMed ID: 18701476
[TBL] [Abstract][Full Text] [Related]
31. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
[TBL] [Abstract][Full Text] [Related]
32. Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity.
Mezencev R; Matyunina LV; Jabbari N; McDonald JF
BMC Cancer; 2016 Mar; 16():236. PubMed ID: 26988558
[TBL] [Abstract][Full Text] [Related]
33. MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways.
Liu C; Xing H; Guo C; Yang Z; Wang Y; Wang Y
Cell Cycle; 2019 Sep; 18(18):2215-2227. PubMed ID: 31286834
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
35. MTH1 suppression enhances the stemness of MCF7 through upregulation of STAT3.
Li J; Wang ZH; Dang YM; Li DN; Liu Z; Dai DP; Cai JP
Free Radic Biol Med; 2022 Aug; 188():447-458. PubMed ID: 35809767
[TBL] [Abstract][Full Text] [Related]
36. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
[TBL] [Abstract][Full Text] [Related]
37. Radiation induces an inflammatory response that results in STAT3-dependent changes in cellular plasticity and radioresistance of breast cancer stem-like cells.
Arnold KM; Opdenaker LM; Flynn NJ; Appeah DK; Sims-Mourtada J
Int J Radiat Biol; 2020 Apr; 96(4):434-447. PubMed ID: 31850822
[No Abstract] [Full Text] [Related]
38. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
39. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
40. Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.
Sengupta S; Nagalingam A; Muniraj N; Bonner MY; Mistriotis P; Afthinos A; Kuppusamy P; Lanoue D; Cho S; Korangath P; Shriver M; Begum A; Merino VF; Huang CY; Arbiser JL; Matsui W; Győrffy B; Konstantopoulos K; Sukumar S; Marignani PA; Saxena NK; Sharma D
Oncogene; 2017 Oct; 36(41):5709-5721. PubMed ID: 28581518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]